CARMEN GARMENDIA: Open Payments
NPI 1417678798 · PASSAIC, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 31 payments from 12 companies in 2025. Trend: 2023 $1,382 · 2024 $436 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $206 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $166 |
| Ardelyx, Inc. | 2 | $130 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Averitas Pharma Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: XIFAXAN, IBSRELA, REPATHA, OTEZLA, PREVNAR 20, Kerendia, QUTENZA, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
